title: Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy.
authors: Department of Infectious Diseases, Austin Health, Melbourne, VIC, Australia. janine.trevillyan@monash.edu
authors: Janine M
authors: JM
authors: Trevillyan
authors: Paul D R
authors: PD
authors: Johnson
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D054312:Buruli Ulcer / Q000628:therapy*; D003646:Debridement; D024841:Fluoroquinolones; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000077266:Moxifloxacin; D019911:Mycobacterium ulcerans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D011239:Prednisolone / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001372:Aza Compounds; D024841:Fluoroquinolones; D005938:Glucocorticoids; D011804:Quinolines; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D011239:Prednisolone; D000077266:Moxifloxacin; D012293:Rifampin; D010878:Piperacillin